On ECHEMI
Home > Drugs > Gastric neurofibroma
Gastric neurofibroma
Gastric neurofibroma is a neurogenic tumor, which is rare in clinical practice, accounting for 10% of benign gastric tumors, and has a high rate of malignant transformation. Patients are mostly middle-aged, with no significant difference between men and women. Gastric neurofibroma is mostly solitary, but can also be part of systemic multiple neurofibromatosis. About 10% of gastric neurofibromas will undergo malignant transformation. It is more common in the lesser curvature of the distal stomach.
  • Site of disease:

    Stomach
  • Infectious :

    Not contagious
  • Frequent population:

    More common in middle-aged people, gender is unclear...
  • Related symptoms:

    Stomach ache nausea indigestion loss of appetite abdominal discomfort
  • Concurrent disease:

Related Drugs
Recombinant human interleukin-2 (Ⅰ) for injection
Indication: Used for the treatment of congenital or acquired immunodeficiency, improving the patient's cellular immune function and anti-infection ability. Treatment of various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, etc. It has a certain therapeutic effect on certain viral, bacillary diseases, and intracellular parasitic infectious diseases, such as hepatitis B, leprosy, tuberculosis, and Candida albicans infection. Used in combination with chemotherapy and radiotherapy to enhance the therapeutic effect and improve immunity. Used for anti-recurrence and anti-metastasis treatment after surgery, chemotherapy and radiotherapy of malignant tumors, and at the same time enhance immunity. Treat malignant pleural, abdominal and pericardial effusions. Used for biological immunotherapy of tumors that are not suitable for surgery, chemotherapy and radiotherapy.
Manufacturer:

Beijing Shougang Gas Company Limited

Matrine Sodium Chloride Injection
Indication: This product is suitable for chronic active hepatitis and chronic persistent hepatitis.
Manufacturer:

Hunan Kelun Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.